SABCS 2021 Monitoring ESR1 Mutations May Optimize Treatment in Metastatic Breast Cancer Publish Date December 13, 2021 Monitoring bESR1mut enabled optimization of the endocrine therapy used with a CDK4/6 inhibitor.